Sigilon Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States51-200 Employees

Sigilon Therapeutics', a wholly owned subsidiary of Eli Lilly and Company, mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. We're based in Cambridge, Mass.

Find Sigilon Therapeutics employees' phone numbers or email addresses

Sigilon Therapeutics Global Highlights

North America
95

United States Of America
95

Europe
1

United Kingdom Of Great Britain And Northern Ireland
1

Sigilon Therapeutics's Leadership

D. P.
Chief Technology Officer
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. K.
Chief Legal Officer
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. Y.
Chief Technical Operations Officer
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. W.
Vp, Head Of Bioanalytical, Biomarker And Cmc Analytical Development
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
O. G. K.
Vice President, Islet Cell Therapy Research
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. K.
Vp, Head Of Mfg / Supply Chain
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. J. M.
Vp Of Finance & Controller
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. H.
Vice President, Intellectual Property Counsel
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Sigilon Therapeutics Employee Metrics

100%

50%

0%

2024

2023

Research
Engineering
Human Resources
Accounting
Consultant
Other
Finance

Contact profiles from Sigilon Therapeutics

Name

Title

Contact Info

Location

Last Update

X. S.
Scientist
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
United StatesMassachusetts
Sep 06, 2024
Z. V.
Associate Scientist
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
United StatesNew York
Jul 27, 2024
C. I.
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Sigilon Therapeutics and Millions of Other Companies
Sign up for full access to Sigilon Therapeutics information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
United StatesMassachusetts
Oct 18, 2024

Frequently Asked Questions

What is Sigilon Therapeutics known for?

Sigilon Therapeutics was founded in 2015 operates in the Biotechnology Research industry. The company's main headquarters is located in 100 Binney St, STE 600 STE 2C Cambridge, MA 02142 US; you can contact the main corporate office by phone at

+1-617-336-****

. Explore Sigilon Therapeutics's company overview page for more information.

What is Sigilon Therapeutics's most common email format?

Sigilon Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Sigilon Therapeutics email formats with LeadIQ.

How many employees does Sigilon Therapeutics have currently?

Sigilon Therapeutics has approximately 51 employees as of February 2024. These team members are located across 2 continents, including North AmericaEurope.

Who are Sigilon Therapeutics's key employees and leadership?

As of February 2024, Sigilon Therapeutics's key employees include:

Chief Technology Officer: D. P.
Chief Legal Officer: M. K.
Chief Technical Operations Officer: S. Y.
Vp, Head Of Bioanalytical, Biomarker And Cmc Analytical Development: J. W.
Vice President, Islet Cell Therapy Research: O. G. K.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking